Jolien Vanhooren, Rani Dobbelaere, Charlotte Derpoorter, Larissa Deneweth, Laurens Van Camp, Anne Uyttebroeck, Barbara De Moerloose, Tim Lammens. CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them.HemaSphere. 2023, 7 (9): e937
Marco V Haselager, Bianca F van Driel, Eduard Perelaer, Dennis de Rooij, Danial Lashgari, Remco Loos, Arnon P Kater, Perry D Moerland, Eric Eldering. In Vitro 3D Spheroid Culture System Displays Sustained T Cell-dependent CLL Proliferation and Survival.HemaSphere. 2023, 7 (9): e938
Thomas Beder, Björn-Thore Hansen, Alina M Hartmann, Johannes Zimmermann, Eric Amelunxen, Nadine Wolgast, Wencke Walter, Marketa Zaliova, Željko Antić, Philippe Chouvarine, Lorenz Bartsch, Malwine J Barz, Miriam Bultmann, Johanna Horns, Sonja Bendig, Jan Kässens, Christoph Kaleta, Gunnar Cario, Martin Schrappe, Martin Neumann, Nicola Gökbuget, Anke Katharina Bergmann, Jan Trka, Claudia Haferlach, Monika Brüggemann, Claudia D Baldus, Lorenz Bastian. The Gene Expression Classifier ALLCatchR Identifies B-cell Precursor ALL Subtypes and Underlying Developmental Trajectories Across Age.HemaSphere. 2023, 7 (9): e939
Kazimierz Groen, Fredrik H Schjesvold, Bronno van der Holt, Mark-David Levin, Maarten R Seefat, Markus Hansson, Maria B L Leys, Josien C Regelink, Anders Waage, Damian Szatkowski, Per Axelsson, Trung Hieu Do, Asta Svirskaite, Ellen van der Spek, Einar Haukas, Dorota Knut-Bojanowska, Paula F Ypma, Cecilie H Blimark, Ulf-Henrik Mellqvist, Niels W C J van de Donk, Pieter Sonneveld, Anja Klostergaard, Annette J Vangsted, Niels Abildgaard, Sonja Zweegman. Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13.HemaSphere. 2023, 7 (9): e940
Meryl Darlington, Pierre Sujobert, Olivier Kosmider, Damien Luque Paz, Sophie Kaltenbach, Martin Figeac, Sandrine Hayette, Nadia Mezaour, Séverine Coquerelle, Anne-Sophie Alary, Audrey Bidet, Yannick Le Bris, Eric Delabesse, Frédéric Davi, Claude Preudhomme, Isabelle Durand-Zaleski, Elizabeth Macintyre. Targeted High-throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in France.HemaSphere. 2023, 7 (9): e943
Fabio Efficace, Wael Al Essa, Uwe Platzbecker, Pasquale Niscola, Giuseppe A Palumbo, Giovanni Caocci, Francesco Cottone, Massimo Breccia, Mario Luppi, Reinhard Stauder, Alessandra Ricco, Duska Petranovic, Frederic Baron, Maria Teresa Voso, Luana Fianchi, Chiara Frairia, Isabella Capodanno, Chiara Sarlo, Marilena Fedele, Roberto Massimo Lemoli, Rosangela Invernizzi, Daniele Vallisa, Nicola Di Renzo, Claudio Fozza, Maribel Doro, Johannes M Giesinger, Marco Vignetti. Health-related Quality of Life Profile of Newly Diagnosed Patients With Myelodysplastic Syndromes by Age, Sex, and Risk Group: A Real-world Study by the GIMEMA.HemaSphere. 2023, 7 (9): e944
Lea Spory, Johannes Zimmermann, Michaela Vossen-Gajcy, Thomas Beder, Lorenz Bastian, Ameera Alsadeq, Dorothee Winterberg, Fotini Vogiatzi, Tim Wirbelauer, Hilal Bhat, Arndt Borkhardt, Sanil Bhatia, Martin Schrappe, Gunnar Cario, Denis M Schewe, Lennart Lenk. AP-1 Transcription Factor Complex Members and are Linked With CNS Infiltration and Inferior Prognosis in Childhood T-ALL.HemaSphere. 2023, 7 (9): e945
Giulia Gabrielli, Roni Shouval, Guido Ghilardi, Marcel van den Brink, Marco Ruella. Harnessing the Gut Microbiota to Potentiate the Efficacy of CAR T Cell Therapy.HemaSphere. 2023, 7 (9): e950
Mikalai Katsin, Dmitri Dormeshkin, Alexander Meleshko, Alexandr Migas, Simon Dubovik, Natalya Konoplya. CAR-T Cell Therapy for Classical Hodgkin Lymphoma.HemaSphere. 2023, 7 (12): e971
Jun Li, Suyu Zong, Yang Wan, Min Ruan, Li Zhang, Wenyu Yang, Xiaojuan Chen, Yao Zou, Yumei Chen, Ye Guo, Peng Wu, Yingchi Zhang, Xiaofan Zhu. Integration of Transcriptomic Features to Improve Prognosis Prediction of Pediatric Acute Myeloid Leukemia With KMT2A Rearrangement.HemaSphere. 2023, 7 (12): e979